Evidence map›Paper›PMID 42205764›Full record

ArticleCase reports in orthopedics2026

Giant Cell Tumor of the Olecranon With a Displaced Pathological Fracture Successfully Treated by Intralesional Curettage and Plate Fixation: A Case Report.

Toshio Kojima, Eiji Osaka, Takao Ishii, Kazuyoshi Nakanishi

Abstract read
In one paragraph

Article in Case reports in orthopedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Toshio KojimaDepartment of Orthopaedic Surgery, Nihon University School of Medicine, Tokyo, Japan, nihon-u.ac.jp.ORCID https://orcid.org/0000-0002-9012-9101
Eiji OsakaDepartment of Orthopaedic Surgery, Kasukabe Medical Center, Saitama, Japan.ORCID https://orcid.org/0000-0002-3429-2238
Takao IshiiDepartment of Orthopaedic Surgery, Kawaguchi Municipal Medical Center, Saitama, Japan, kawaguchi-mmc.org.ORCID https://orcid.org/0009-0002-3228-9542
Kazuyoshi NakanishiDepartment of Orthopaedic Surgery, Nihon University School of Medicine, Tokyo, Japan, nihon-u.ac.jp.ORCID https://orcid.org/0000-0001-7497-8667

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell tumor of bone (GCTB) is a locally aggressive intermediate bone tumor that typically arises at the epiphysis of long bones. GCTB occurring in the olecranon is extremely rare, and the optimal surgical strategy when complicated by pathological fractures with marked displacement involving the articular surface remains unclear. In this case, the fracture site was significantly displaced. Through the gap created by the displacement, we performed thorough curettage of the lesion, anatomical reduction, synthetic bone grafting, and plate fixation. Histopathological examination confirmed GCTB. At 9 months postoperatively, the patient was pain-free, with a full range of motion in the elbow joint and no functional limitations. The patient remained asymptomatic at 10 years postoperatively, and imaging showed no evidence of local recurrence. This case suggests that, in olecranon GCTB complicated by pathological fracture, access through the fracture gap may allow thorough intralesional curettage and anatomical reduction and fixation in certain situations, potentially leading to favorable long-term functional and oncological outcomes. However, pathological fracture in GCTB remains a clinical challenge and should not generally be considered advantageous.

Indexed as

elbowgiant cell tumor of boneintralesional curettageolecranonpathological fractureplate fixation

Identifiers

PMID42205764
PMCPMC13205569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.